LifeScan v. Polymer Technology International
This article was originally published in The Gray Sheet
Executive Summary
Federal appeals court ruling on Oct. 18 overturns a lower court's decision that denied Johnson & Johnson subsidiary LifeScan a preliminary injunction barring Polymer from marketing glucose test strips. The appeals court concludes that the district court order did "not indicate that there was any weighing of the evidence or that there was any attempt to discern the merits of the parties' arguments." The district court must "undertake sufficient fact finding" to "redetermine the merits of LifeScan's preliminary injunction motion," the appeals court notes. The trial on the case is expected to begin in Jan. 1995, LifeScan says. The firm filed suit against Polymer in December 1993 alleging that Polymer's First Choice test strips infringed patents related to Lifescan's One Touch test technology
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.